Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

93 projects found matching your search criteria :

  1. The role of the endogenuous opioid system in prosocial behavior

    Call: OPUS 11 , Panel: NZ4

    Principal investigator: dr hab. Jan Rodriguez Parkitna

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  2. Modulation of amygdala neural network activity by the 5-HT7 receptor

    Call: OPUS 11 , Panel: NZ4

    Principal investigator: prof. Krzysztof Tokarski

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  3. Determination of the mechanisms and potential targets for neuropathic pain therapy by investigating pharmacological inte...

    Call: PRELUDIUM 12 , Panel: NZ7

    Principal investigator: Anna Piotrowska-Murzyn

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  4. The role of codependent 5-HT1a and 5-HT7 receptor signalling in the hippocampal stress response

    Call: PRELUDIUM 12 , Panel: NZ4

    Principal investigator: Marcin Siwiec

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  5. The role of brain glutamatergic system in the neuroendocrine regulation of cytochrome P450 expression and activity in th...

    Call: OPUS 12 , Panel: NZ7

    Principal investigator: prof. Władysława Daniel

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  6. Evaluation of interactions of aripiprazole, the atypical amtipsychotic drug, with the selected antidepressants in the ra...

    Call: OPUS 12 , Panel: NZ7

    Principal investigator: dr hab. Zofia Rogóż

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  7. Modulation of inflammatory processes using new agonists of the formyl peptide receptors ALX/FPR2 as a new therapeutic st...

    Call: HARMONIA 9 , Panel: NZ7

    Principal investigator: prof. Agnieszka Basta-Kaim

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  8. How microglia-astrocyte interaction affects neuronal functioning in the dopaminergic system. Analysis of the protective ...

    Call: OPUS 14 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Kuter-Nowak

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  9. Novel hope for diseased joints: a polymer-based treatment to promoteregenerative strategies for patients with osteoarthr...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Marta Kędziora

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  10. New approach to the treatment of Alzheimer's disease targetingresolution of inflammation and modulation of biomechanical...

    Call: OPUS 22 , Panel: NZ4

    Principal investigator: prof. Agnieszka Basta-Kaim

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  11. Translational and interdisciplinary investigation of phenotypes of reinforcement sensitivity as predictors of the respon...

    Call: OPUS 22 , Panel: HS6

    Principal investigator: dr hab. Rafał Ryguła

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  12. The evaluation of therapeutic potential of β-caryophyllene in animal schizophrenia model - behavioral and molecular stud...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Magdalena Białoń

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  13. The role of cognitive bias in individual vulnerability to to the transition from controlled use to uncontrolled abuse of...

    Call: OPUS 16 , Panel: NZ7

    Principal investigator: dr hab. Rafał Ryguła

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  14. The influence of muscarinic acetylcholine receptors (M1, M4 and M5) and serotonergic 5-HT1A receptor modulation on cogni...

    Call: PRELUDIUM 16 , Panel: NZ7

    Principal investigator: dr Paulina Cieślik

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  15. The role of endoplasmic reticulum stress in the pathomechanisms of early-life stress-induced dysfunction of the prefrona...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Chocyk

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  16. Selective activation of non-nuclear Estrogen Receptor signaling with PaPE-1 as a novel therapeutic approach for sporadic...

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: prof. Małgorzata Kajta

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  17. Chronic pain in obesity: from cellular mechanisms to new strategies for targeted therapy.

    Call: SONATA 17 , Panel: NZ5

    Principal investigator: dr Anna Piotrowska-Murzyn

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  18. Development of a comprehensive set of computational tools for the search of new ligands of particular receptor - case st...

    Call: OPUS 16 , Panel: NZ2

    Principal investigator: dr Sabina Podlewska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  19. Wpływ wybranych chemokin na właściwości komórek nerwowych i przekaźnictwo synaptyczne w obszarze kompleksu ciała migdało...

    Call: ETIUDA 7 , Panel: NZ4

    Principal investigator: Joanna Sowa

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  20. Endocannabinoid regulation of the motivational tone at the mesolimbic system driven by inflammation

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Starowicz-Bubak

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  21. Pharmacological modulation of histamine H3 and H4 receptors - a new perspective in the treatment of neuropathic pain

    Call: SONATA 15 , Panel: NZ7

    Principal investigator: dr Katarzyna Popiołek-Barczyk

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  22. Involvement of astrocytes in the neuroprotective mechanism evoked by enhancement of noradrenergic transmission in trasng...

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Justyna Barut

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  23. The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic ...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: dr Katarzyna Szczepańska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  24. Selective PPARγ modulation by amorfrutin B as a novel therapeutic approach to chemotherapy-induced damage to mammalian b...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Bernadeta Pietrzak-Wawrzyńska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  25. The cross-talk between 5-HTR2A and mGluR2 as a window for antidepressant effects of psilocybin.

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: prof. Andrzej Pilc

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  26. The role of kynurenine pathway in neurophatic pain in view of innovative treatment approaches

    Call: SONATA 9 , Panel: NZ4

    Principal investigator: dr Ewelina Rojewska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  27. Investigation of the effects and mechanisms of action of Deep Brain Stimulation in two animal models of treatment-resist...

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  28. Zinc deficient diet as a trigger for treatment-resistant depression in chronically stressed mice. Understanding the mech...

    Call: OPUS 19 , Panel: NZ5

    Principal investigator: dr hab. Bernadeta Szewczyk

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  29. The effect of the metabotropic glutamatergic receptor ligands on potentiating the antidepressant-like actvity of scopola...

    Call: PRELUDIUM 10 , Panel: NZ7

    Principal investigator: Karolina Podkowa

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  30. The role of selected signaling pathways in zinc deficiency

    Call: OPUS 10 , Panel: NZ4

    Principal investigator: prof. Gabriel Nowak

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  31. Search for new targets for an effective therapy of neuropathic pain and enhancement of opioids effects basing on the exa...

    Call: OPUS 11 , Panel: NZ4

    Principal investigator: prof. Joanna Mika

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  32. Comparative effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ) and olanzapine on the cognitive dysfunction meas...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Wąsik

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  33. Modified maternal diet as a factor of autism spectrum disorders in offspring - preclinical molecular studies on prefront...

    Call: PRELUDIUM 15 , Panel: NZ7

    Principal investigator: Kinga Gawlińska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  34. Impact of pharmacogenetic profiles on depression treatment outcomes

    Call: SONATINA 5 , Panel: NZ2

    Principal investigator: dr Małgorzata Borczyk

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  35. Investigating the role of the focal adhesion kinase and its related signaling pathways in glucocorticoid- and stress-ind...

    Call: PRELUDIUM 20 , Panel: NZ4

    Principal investigator: Michał Wilczkowski

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  36. Maternal obesity as a risk factor of autism spectrum disorder in offspring - in search of the role of the gut microbiota...

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: dr Dawid Gawliński

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  37. The role of the immune checkpoints in the pathomechanism of depressive disorders.

    Call: OPUS 22 , Panel: NZ6

    Principal investigator: prof. Marta Kubera

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  38. Enhancement of antidepressant therapy by combined administration of hyperforin and ketamine: behavioral and molecular st...

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Bartłomiej Pochwat

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  39. Brain cytochrome P450 as a new target for the treatment of neurological and psychiatric diseases. Studies with human neu...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: prof. Władysława Daniel

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  40. Role of the NLRP3 inflammasome in the mechanisms of action of antidepressant drugs - study in an animal model of depress...

    Call: PRELUDIUM 9 , Panel: NZ7

    Principal investigator: dr Ewa Trojan

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  41. The effect of chronic treatment with iasenapine and iloperidone on the expression and activity of cytochrome P450 in the...

    Call: PRELUDIUM 16 , Panel: NZ7

    Principal investigator: dr Przemysław Danek

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  42. Ocena roli wybranych białek neuronalnych i mikroglejowych w patogenezie schizofrenii - badania w modelu zwierzęcym.

    Call: ETIUDA 7 , Panel: NZ4

    Principal investigator: Katarzyna Chamera

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  43. In vivo effects, underlying signaling pathways and mechanism of action of ghrelin receptor agonist against pathological ...

    Call: SONATA 15 , Panel: NZ7

    Principal investigator: dr Piotr Chmielarz

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  44. Neurochemical basis of antidepressive properties of psychedelics in rodent model of depression

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Krystyna Gołembiowska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  45. Molecular characteristics of stress-resilient phenotype using mice models.

    Call: OPUS 12 , Panel: NZ4

    Principal investigator: prof. Marta Dziedzicka-Wasylewska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  46. Sensitivity to negative feedback as a cognitive biomarker of depression in an animal model

    Call: OPUS 12 , Panel: NZ4

    Principal investigator: dr hab. Rafał Ryguła

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  47. Development of unique molecular probes: low-basicity agonists for the study of 5-HT7 receptor function

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: prof. Andrzej Bojarski

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  48. The influence of perinatal exposure to selective serotonin reuptake inhibitors on the structure and functions of mice do...

    Call: OPUS 14 , Panel: NZ4

    Principal investigator: prof. Grzegorz Hess

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  49. Opioid-induced analgesia and hyperalgesia in neuropathic pain - mechanisms and druggable targets

    Call: OPUS 15 , Panel: NZ7

    Principal investigator: prof. Barbara Przewłocka

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  50. New strategies in neuropathic pain pharmacotherapy based on the modulation of the functions of chemokine receptors CCR2 ...

    Call: PRELUDIUM 15 , Panel: NZ7

    Principal investigator: dr Klaudia Kwiatkowski

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy